Nextera

Nectin Therapeutics

This company develops novel immunotherapeutic antibodies and antibody-drug conjugates for patients with solid and haematological cancers.

ArgenX

This company develops and commercialises antibody-based therapies to treat patients suffering from severe autoimmune diseases and cancer.

AbCellera

This company develops antibody discovery technology and therapeutic medicines for biotechnology and pharmaceutical partners to treat cancer, autoimmune disorders and infectious diseases.

AbCellera Biologics

The company develops antibody-based medicines and discovery technologies for pharmaceutical and biotechnology partners to treat cancer, autoimmune disorders and infectious diseases.

Xaira

The company develops artificial intelligence platforms to design and develop antibody-based medicines for patients with various diseases.

Nexosome Oncology

The company develops exosome-based blood tests for early-stage cancer detection and provides biomarker discovery services for pharmaceutical and biotechnology organisations.

Mestag Therapeutics

This company develops antibody therapies targeting fibroblast immunology for patients with cancer and inflammatory diseases.

Arxx Therapeutics

This biotechnology firm develops monoclonal antibody therapies for patients suffering from chronic inflammatory and fibrotic diseases.